Analysts See $1.90 EPS for CVS Health Corporation (CVS)

January 13, 2018 - By marketbeat

 Analysts See $1.90 EPS for CVS Health Corporation (CVS)
Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It worsened, as 60 investors sold CVS Health Corporation shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported.
Spinnaker Trust has invested 0.45% in CVS Health Corporation (NYSE:CVS). Alpine Woods Invsts Llc reported 0.92% in CVS Health Corporation (NYSE:CVS). The Virginia-based Virginia Retirement System Et Al has invested 0.31% in CVS Health Corporation (NYSE:CVS). Lombard Odier Asset Mgmt (Europe) invested in 0.06% or 12,216 shares. First Comml Bank Of Omaha invested in 0.11% or 21,031 shares. Raymond James Associate has invested 0.26% of its portfolio in CVS Health Corporation (NYSE:CVS). Winfield Associates owns 3,835 shares. Howard reported 2,861 shares or 0.04% of all its holdings. Edmp invested in 0.9% or 12,309 shares. First Wilshire Mgmt invested 0.09% of its portfolio in CVS Health Corporation (NYSE:CVS). Atlanta Cap L L C holds 0.07% or 159,290 shares in its portfolio. Moreover, Nelson Roberts Investment Limited Liability has 0.17% invested in CVS Health Corporation (NYSE:CVS) for 6,434 shares. 22,985 were reported by Connable Office. Bryn Mawr Tru Communication owns 17,696 shares. 127,578 are owned by Seaward Mgmt L P.

Since August 16, 2017, it had 0 insider purchases, and 7 selling transactions for $58.32 million activity. Moriarty Thomas M also sold $7.19M worth of CVS Health Corporation (NYSE:CVS) shares. $3.22M worth of CVS Health Corporation (NYSE:CVS) was sold by Foulkes Helena. On Monday, September 18 the insider Roberts Jonathan C sold $7.13M. Denton David M sold $18.88M worth of stock or 237,078 shares. Another trade for 2,500 shares valued at $199,050 was sold by SWIFT RICHARD J.

Analysts expect CVS Health Corporation (NYSE:CVS) to report $1.90 EPS on February, 8.They anticipate $0.19 EPS change or 11.11 % from last quarter’s $1.71 EPS. CVS’s profit would be $1.92B giving it 10.37 P/E if the $1.90 EPS is correct. After having $1.50 EPS previously, CVS Health Corporation’s analysts see 26.67 % EPS growth. The stock decreased 0.30% or $0.24 during the last trading session, reaching $78.78. About 7.10M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 13, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 65 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Citigroup given on Monday, November 13. The firm earned “Buy” rating on Wednesday, August 19 by Evercore. The firm has “Neutral” rating by Citigroup given on Friday, November 3. The company was maintained on Monday, May 9 by Citigroup. On Tuesday, November 7 the stock rating was maintained by Jefferies with “Hold”. Needham upgraded the shares of CVS in report on Friday, November 10 to “Buy” rating. Oppenheimer maintained it with “Outperform” rating and $119.0 target in Friday, August 28 report. Jefferies maintained the stock with “Buy” rating in Thursday, May 12 report. The firm has “Overweight” rating by JP Morgan given on Monday, November 2. Loop Capital maintained CVS Health Corporation (NYSE:CVS) rating on Tuesday, November 7. Loop Capital has “Hold” rating and $73 target.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $79.81 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 16.23 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS-Aetna Deal Could Heighten Experiential Retail” on January 11, 2018, also Gurufocus.com with their article: “Tandem Investment Advisors, Inc. Buys CVS Health Corp, Cognizant Technology …” published on January 09, 2018, Finance.Yahoo.com published: “CVS Health expects tax overhaul to boost cash flow, shares rise” on January 04, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: “CVS Merger Is A Positive Sign” published on January 09, 2018 as well as Prnewswire.com‘s news article titled: “CVS Health Corporation Announces Quarterly Dividend” with publication date: December 29, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.